vs
AVINO SILVER & GOLD MINES LTD(ASM)与CUMBERLAND PHARMACEUTICALS INC(CPIX)财务数据对比。点击上方公司名可切换其他公司
AVINO SILVER & GOLD MINES LTD的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.5倍($21.0M vs $13.7M),AVINO SILVER & GOLD MINES LTD净利率更高(36.6% vs -10.3%,领先46.9%),AVINO SILVER & GOLD MINES LTD同比增速更快(44.0% vs 31.1%),过去两年AVINO SILVER & GOLD MINES LTD的营收复合增速更高(51.1% vs 26.9%)
阿维诺金银矿业有限公司是一家加拿大矿业企业,主要从事银、金、铜等贵金属及基本金属的勘探、开发与生产,核心运营资产为位于墨西哥杜兰戈州的旗舰阿维诺矿区,产品供应全球大宗商品市场。
坎伯兰制药是一家专科制药企业,专注于开发、生产和商业化品牌处方药物,核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域,主要运营市场为美国,为相关医护人员与患者提供服务。
ASM vs CPIX — 直观对比
营收规模更大
ASM
是对方的1.5倍
$13.7M
营收增速更快
ASM
高出12.9%
31.1%
净利率更高
ASM
高出46.9%
-10.3%
两年增速更快
ASM
近两年复合增速
26.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $21.0M | $13.7M |
| 净利润 | $7.7M | $-1.4M |
| 毛利率 | 47.1% | 83.6% |
| 营业利润率 | — | -10.0% |
| 净利率 | 36.6% | -10.3% |
| 营收同比 | 44.0% | 31.1% |
| 净利润同比 | 558.9% | 25.8% |
| 每股收益(稀释后) | $0.05 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASM
CPIX
| Q4 25 | — | $13.7M | ||
| Q3 25 | $21.0M | $8.3M | ||
| Q2 25 | $21.8M | $10.8M | ||
| Q1 25 | $18.8M | $11.7M | ||
| Q4 24 | — | $10.4M | ||
| Q3 24 | $14.6M | $9.1M | ||
| Q2 24 | $14.8M | $9.8M | ||
| Q1 24 | $12.4M | $8.5M |
净利润
ASM
CPIX
| Q4 25 | — | $-1.4M | ||
| Q3 25 | $7.7M | $-1.9M | ||
| Q2 25 | $2.9M | $-740.7K | ||
| Q1 25 | $5.6M | $1.3M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | $1.2M | $-1.5M | ||
| Q2 24 | $1.2M | $-1.1M | ||
| Q1 24 | $599.0K | $-1.9M |
毛利率
ASM
CPIX
| Q4 25 | — | 83.6% | ||
| Q3 25 | 47.1% | 88.1% | ||
| Q2 25 | 46.9% | 81.4% | ||
| Q1 25 | 56.1% | 87.8% | ||
| Q4 24 | — | 81.1% | ||
| Q3 24 | 39.1% | 85.4% | ||
| Q2 24 | 31.8% | 82.6% | ||
| Q1 24 | 18.9% | 81.5% |
营业利润率
ASM
CPIX
| Q4 25 | — | -10.0% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -6.9% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | — | -10.4% | ||
| Q1 24 | — | -22.0% |
净利率
ASM
CPIX
| Q4 25 | — | -10.3% | ||
| Q3 25 | 36.6% | -23.4% | ||
| Q2 25 | 13.1% | -6.8% | ||
| Q1 25 | 29.8% | 10.7% | ||
| Q4 24 | — | -18.2% | ||
| Q3 24 | 8.0% | -17.0% | ||
| Q2 24 | 8.4% | -11.0% | ||
| Q1 24 | 4.8% | -22.9% |
每股收益(稀释后)
ASM
CPIX
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $0.05 | $-0.13 | ||
| Q2 25 | $0.02 | $-0.05 | ||
| Q1 25 | $0.04 | $0.08 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $0.01 | $-0.11 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $0.00 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $11.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.1M | $24.9M |
| 总资产 | $221.9M | $76.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASM
CPIX
| Q4 25 | — | $11.4M | ||
| Q3 25 | $57.3M | $15.2M | ||
| Q2 25 | $37.3M | $16.1M | ||
| Q1 25 | $26.6M | $15.1M | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | $7.8M | $17.5M | ||
| Q2 24 | $5.3M | $17.3M | ||
| Q1 24 | $3.5M | $18.5M |
股东权益
ASM
CPIX
| Q4 25 | — | $24.9M | ||
| Q3 25 | $182.1M | $26.1M | ||
| Q2 25 | $144.8M | $28.0M | ||
| Q1 25 | $132.3M | $28.7M | ||
| Q4 24 | — | $22.9M | ||
| Q3 24 | $114.5M | $24.8M | ||
| Q2 24 | $112.2M | $26.3M | ||
| Q1 24 | $107.8M | $27.5M |
总资产
ASM
CPIX
| Q4 25 | — | $76.8M | ||
| Q3 25 | $221.9M | $65.9M | ||
| Q2 25 | $174.7M | $67.9M | ||
| Q1 25 | $157.7M | $69.9M | ||
| Q4 24 | — | $75.6M | ||
| Q3 24 | $135.4M | $76.7M | ||
| Q2 24 | $133.7M | $78.5M | ||
| Q1 24 | $128.6M | $81.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $8.3M | $3.0K |
| 自由现金流经营现金流 - 资本支出 | — | $3.0K |
| 自由现金流率自由现金流/营收 | — | 0.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $4.8M |
8季度趋势,按日历期对齐
经营现金流
ASM
CPIX
| Q4 25 | — | $3.0K | ||
| Q3 25 | $8.3M | $187.2K | ||
| Q2 25 | $8.3M | $843.8K | ||
| Q1 25 | $758.0K | $3.9M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $4.1M | $475.5K | ||
| Q2 24 | $1.1M | $-855.7K | ||
| Q1 24 | $2.3M | $-2.1M |
自由现金流
ASM
CPIX
| Q4 25 | — | $3.0K | ||
| Q3 25 | — | $163.4K | ||
| Q2 25 | — | $817.3K | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $460.1K | ||
| Q2 24 | — | $-862.8K | ||
| Q1 24 | — | $-2.2M |
自由现金流率
ASM
CPIX
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 32.9% | ||
| Q4 24 | — | 18.2% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | -8.8% | ||
| Q1 24 | — | -25.6% |
资本支出强度
ASM
CPIX
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.5% |
现金转化率
ASM
CPIX
| Q4 25 | — | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 2.92× | — | ||
| Q1 25 | 0.13× | 3.10× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 3.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图